Results 21 to 30 of about 14,074 (215)

Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease. [PDF]

Eye (Lond), 2023
Zloto O, Rosset A, Priel A, Landau-Prat D, Cukierman-Yaffe T, Shavit R, Agmon-Levin N, Ben Simon GJ, Sagiv O.   +8 more
europepmc   +3 more sources

Thyroid Stimulating Immunoglobulins

Journal of the Royal College of Physicians of London, 1984
Donald Munro
openalex   +2 more sources

Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient area [PDF]

Scientific Reports
Background Selenium (Se) status may influence activity and treatment response in thyroid eye disease (TED), but evidence from Se‑sufficient regions is limited.
Su Min Sung, Dong Cheol Lee
doaj   +2 more sources

SAT-621 An Atypical Case of Nivolumab-Induced Thyroiditis with Persistently Elevated Thyroid-Stimulating Immunoglobulin

J Endocr Soc, 2019
Kirk D.
europepmc   +2 more sources

Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves' disease. [PDF]

Front Endocrinol (Lausanne)
Yao P, Xie Y, Wang Y, Liang C, Huang B.
europepmc   +3 more sources

SAT-422 Evaluation of the Siemens Thyroid Stimulating Immunoglobulin (TSI) Assay for Diagnosis and Prognosis of Graves’ Disease [PDF]

J Endocr Soc, 2020
Paul H, Moledina N, Robinson J, Chin A, Kline G, Sadrzadeh H.   +5 more
europepmc   +3 more sources

Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice [PDF]

Genes and Immunity, 2010
B Rapoport, Robert W Williams, Sandra M Mclachlan   +2 more
exaly   +2 more sources

Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease [PDF]

Journal of Clinical Endocrinology and Metabolism
Pu Xie, Qinglei Yin, Liyun Shen
exaly   +2 more sources

Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease

Ophthalmology and Therapy, 2023
Introduction The aim of this study was to investigate changes in the Clinical Activity Score, serum thyroid-stimulating hormone receptor antibody and thyroid-stimulating immunoglobulin levels, chorioretinal blood vessels, and extraocular muscle thickness
Jaekyoung Lee, Dong Cheol Lee
doaj   +1 more source

The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease. [PDF]

PLoS ONE, 2015
Osteoporosis-related fractures are one of the complications of Graves' disease. This study hypothesized that the different actions of thyroid-stimulating hormone receptor (TSHR) antibodies, both stimulating and blocking activities in Graves' disease ...
Sun Wook Cho, Jae Hyun Bae, Gyeong Woon Noh, Ye An Kim, Min Kyong Moon, Kyoung Un Park, Junghan Song, Ka Hee Yi, Do Joon Park, June-Key Chung, Bo Youn Cho, Young Joo Park   +11 more
doaj   +1 more source